Literature DB >> 21998347

Should we use total mortality rather than cancer specific mortality to judge cancer screening programmes? Yes.

James Penston1.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21998347     DOI： 10.1136/bmj.d6395

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  17 in total

1.  Should we expect all-cause mortality reductions in large screening studies?

Authors:  Kevin K Dobbin; Mark Ebell
Journal:  Br J Gen Pract       Date:  2018-06       Impact factor: 5.386

2.  Long-Term Follow-Up of Patients Undergoing Resection of TNM Stage I Colorectal Cancer: An Analysis of Tumour and Host Determinants of Outcome.

Authors:  David Mansouri; Arfon G Powell; James H Park; Donald C McMillan; Paul G Horgan
Journal:  World J Surg       Date:  2016-06       Impact factor: 3.352

3.  Mortality and recurrence patterns of breast cancer patients diagnosed under a screening programme versus comparable non-screened breast cancer patients from the same population: analytical survey from 2002 to 2012.

Authors:  A García Fernández; C Chabrera; M García Font; M Fraile; J M Lain; S Gónzalez; C Corral; M Torras; J Torres; M Teixido; I Barco; R López; C Gónzalez; A Pessarrodona; N Giménez
Journal:  Tumour Biol       Date:  2013-10-09

4.  The Impact of Cancer Screening on All-Cause Mortality.

Authors:  Andreas Stang; Karl-Heinz Jöckel
Journal:  Dtsch Arztebl Int       Date:  2018-07-23       Impact factor: 5.594

5.  Response.

Authors:  Danielle Kasperavicius; Neil R Bell; Roland Grad; James A Dickinson; Ainsley Elizabeth Moore; Harminder Singh; Brett D Thombs; Brenda J Wilson
Journal:  Can Fam Physician       Date:  2017-11       Impact factor: 3.275

6.  Neoadjuvant Intra-Arterial Cytoreductive Chemotherapy for Lacrimal Gland Adenoid Cystic Carcinoma: A Long-Term Follow-up Study of a Trimodal Strategy.

Authors:  David T Tse; Pasquale W Benedetto; Brian C Tse; William J Feuer
Journal:  Am J Ophthalmol       Date:  2022-04-02       Impact factor: 5.488

7.  Predicting survival after liver transplantation in patients with hepatocellular carcinoma using the LiTES-HCC score.

Authors:  David Goldberg; Alejandro Mantero; Craig Newcomb; Cindy Delgado; Kimberly A Forde; David E Kaplan; Binu John; Nadine Nuchovich; Barbara Dominguez; Ezekiel Emanuel; Peter P Reese
Journal:  J Hepatol       Date:  2021-01-13       Impact factor: 30.083

8.  Accurate long-term prediction of death for patients with cirrhosis.

Authors:  David Goldberg; Alejandro Mantero; David Kaplan; Cindy Delgado; Binu John; Nadine Nuchovich; Ezekiel Emanuel; Peter P Reese
Journal:  Hepatology       Date:  2022-04-01       Impact factor: 17.298

9.  Screening mammography: what good is it and how can we know if it works?

Authors:  Michael W Vannier
Journal:  J Natl Cancer Inst       Date:  2012-07-17       Impact factor: 13.506

10.  The rs2910164 Genetic Variant of miR-146a-3p Is Associated with Increased Overall Mortality in Patients with Follicular Variant Papillary Thyroid Carcinoma.

Authors:  Marta Kotlarek; Anna Kubiak; Małgorzata Czetwertyńska; Michał Świerniak; Wojciech Gierlikowski; Monika Kolanowska; Elwira Bakuła-Zalewska; Sissy M Jhiang; Krystian Jażdżewski; Anna Wójcicka
Journal:  Int J Mol Sci       Date:  2018-02-26       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.